Depressive Disorder, Major: all 2,805 studies

Page 10 of 29. Open to participants first (565), then studies with results posted, then the rest; newest registration first within each.

• An Investigation of Early Life Stress and DepressionCompletedNCT01701258Phase 1Results posted
• Ketamine in the Treatment of Suicidal DepressionCompletedNCT01700829Phase 4Results posted
• PET Imaging of mGLuR5 With Drug ChallengeCompletedNCT01691092Not applicableResults posted
• Feasibility Study to Test Clinical Efficacy of Low Energy AC Magnetic Field to Treat Major DepressionCompletedNCT01683019Not applicableResults posted
• Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive DisorderCompletedNCT01670279Phase 1Results posted
• Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for DepressionCompletedNCT01670019Phase 4Results posted
• Ketamine Versus Placebo for Treatment Resistant Major Depressive DisorderCompletedNCT01667926Not applicableResults posted
• A Study of Ketamine in Patients With Treatment-resistant DepressionCompletedNCT01627782Phase 2Results posted
• Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED)CompletedNCT01625845Phase 2Results posted
• Vilazodone for Treatment of Geriatric DepressionCompletedNCT01608295Phase 4Results posted
• Internet Based Cognitive Behavioral Therapy Effects on Depressive Cognitions and Brain FunctionCompletedNCT01598922Not applicableResults posted
• Behavior During Experimentally Induced PainCompletedNCT01594528Not applicableResults posted
• Focal Electroconvulsive Therapy for DepressionCompletedNCT01589315Phase 2/3Results posted
• Ketamine Infusion for Treatment-resistant Major Depressive DisorderCompletedNCT01582945Not applicableResults posted
• Past Pain Experience and Perception of Experimental PainCompletedNCT01575912Results posted
• Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian CountriesCompletedNCT01571453Phase 3Results posted
• Contingency Management of Alcohol Abuse in the Severely Mentally ILLCompletedNCT01567943Not applicableResults posted
• Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive DisorderCompletedNCT01564862Phase 2Results posted
• Pioglitazone in Patients With Mood DisordersCompletedNCT01559857Phase 4Results posted
• Ketamine in the Treatment of DepressionCompletedNCT01558063Phase 2Results posted
• Glutamatergic and GABAergic Mediators of Antidepressant Response in Major DepressionCompletedNCT01557946Phase 4Results posted
• Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022)TerminatedNCT01554176Phase 2Results posted
• Cognitive Therapy for Unipolar Depression: Efficacy of a Dilemma-Focused InterventionCompletedNCT01542957Not applicableResults posted
• Transcranial Laser Therapy for Major Depressive DisorderCompletedNCT01538199Not applicableResults posted
• Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in Depressed TeensCompletedNCT01502033Not applicableResults posted
• A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)CompletedNCT01500200Phase 2Results posted
• Efficacy Study of Korean Red Ginseng to Treat DepressionCompletedNCT01496248Not applicableResults posted
• Beat the Blues in Pregnancy Study - Transcranial Magnetic StimulationCompletedNCT01492309Not applicableResults posted
• A Study of Vortioxetine (Lu AA21004) in Comparison to Agomelatine in Adults Suffering From Major Depression With Inadequate Response to Previous MedicationCompletedNCT01488071Phase 3Results posted
• Life Goals Collaborative Care to Improve Health Outcomes in Mental DisordersCompletedNCT01487668Not applicableResults posted
• Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)CompletedNCT01485887Phase 3Results posted
• A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive DisorderCompletedNCT01482221Phase 2Results posted
• Stimulant Enhancement of Well-Being Therapy for DepressionTerminatedNCT01478113Not applicableResults posted
• Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive DisorderCompletedNCT01473394Phase 4Results posted
• Safety and Efficacy of Vilazodone in Major Depressive DisorderCompletedNCT01473381Phase 4Results posted
• Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive DisorderCompletedNCT01469377Phase 2Results posted
• Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and IrritabilityCompletedNCT01464229Phase 4Results posted
• A Study to Evaluate the Effect of Clarithromycin on LY2216684CompletedNCT01460407Phase 1Results posted
• A Study to Evaluate the Effect of Genotype on LY2216684CompletedNCT01460381Phase 1Results posted
• Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive DisorderCompletedNCT01447576Phase 2Results posted
• Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)CompletedNCT01441440Phase 3Results posted
• SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension StudyTerminatedNCT01436175Phase 3Results posted
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderCompletedNCT01436162Phase 3Results posted
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderCompletedNCT01436149Phase 3Results posted
• SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderCompletedNCT01435759Phase 2Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)CompletedNCT01432457Phase 4Results posted
• Wake Therapy in the Treatment of DepressionCompletedNCT01431573Not applicableResults posted
• Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive DisorderCompletedNCT01428661Phase 2/3Results posted
• Sustaining Remission of Psychotic DepressionCompletedNCT01427608Phase 4Results posted
• Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)TerminatedNCT01426516Not applicableResults posted
• Major Depressive Disorder With Mixed Features - ExtensionCompletedNCT01423253Phase 3Results posted
• Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive DisorderCompletedNCT01422213Phase 3Results posted
• VA Augmentation and Switching Treatments for Improving Depression OutcomesCompletedNCT01421342Phase 3Results posted
• Major Depressive Disorder (MDD) With Mixed Features - Flexible DoseCompletedNCT01421134Phase 3Results posted
• Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive DisorderCompletedNCT01415154Not applicableResults posted
• Study Using Pregnenolone to Treat Bipolar DepressionCompletedNCT01409096Phase 4Results posted
• Buprenorphine for Treatment Resistant DepressionCompletedNCT01407575Phase 3Results posted
• A Study to Evaluate the Effect of Food on LY2216684CompletedNCT01389765Phase 1Results posted
• A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy SubjectsCompletedNCT01389752Phase 1Results posted
• A Study of LY2216684 in Healthy ParticipantsCompletedNCT01380691Phase 1Results posted
• Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive DisorderCompletedNCT01377194Phase 3Results posted
• A Study of LY2216684 in Healthy FemalesCompletedNCT01373931Phase 1Results posted
• A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDDCompletedNCT01372150Phase 3Results posted
• A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDDCompletedNCT01371734Phase 3Results posted
• A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDDCompletedNCT01371721Phase 3Results posted
• A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDDCompletedNCT01371708Phase 3Results posted
• Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive DisorderCompletedNCT01370733Phase 3Results posted
• A Study of LY2216684 in Participants With Major Depression DisorderCompletedNCT01370499Phase 3Results posted
• Deplin® P.L.U.S. Program (Progress Through Learning Understanding & Support)CompletedNCT01369030Results posted
• Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual DysfunctionCompletedNCT01364649Phase 3Results posted
• Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)CompletedNCT01360866Phase 3Results posted
• Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)CompletedNCT01360645Phase 3Results posted
• Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)CompletedNCT01360632Phase 3Results posted
• Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive DisorderCompletedNCT01355081Phase 3Results posted
• Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino PatientsTerminatedNCT01353963Results posted
• Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive DisorderTerminatedNCT01337609Phase 4Results posted
• European Deep Brain Stimulation (DBS) Depression StudyCompletedNCT01331330Not applicableResults posted
• Efficacy and Safety of Cranial Electrical Stimulation (CES) for Major Depressive Disorder (MDD)CompletedNCT01325532Not applicableResults posted
• Open-label Safety Extension Study of 15 and 20 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in AdultsCompletedNCT01323478Phase 3Results posted
• Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)CompletedNCT01312922Phase 3Results posted
• Intranasal Ketamine in Treatment-Resistant DepressionCompletedNCT01304147Not applicableResults posted
• A Study in Prevention of Re-emergence of Depression SymptomsCompletedNCT01299272Phase 3Results posted
• A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.TerminatedNCT01288079Phase 2Results posted
• A Study of the Effect of LY2216684 on LorazepamCompletedNCT01275144Phase 1Results posted
• Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) StudyCompletedNCT01269710Results posted
• A Study of LY2216684 and Digoxin in Healthy SubjectsCompletedNCT01266590Phase 1Results posted
• A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake InhibitorsCompletedNCT01263223Phase 1Results posted
• A Study of LY2216684 in Healthy Participants Receiving Albuterol or PropanololCompletedNCT01263197Phase 1Results posted
• A Study of LY2216684 and Warfarin in Healthy SubjectsCompletedNCT01263119Phase 1Results posted
• A Study of LY2216684 and Theophylline in Healthy SubjectsCompletedNCT01263106Phase 1Results posted
• A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of ClopidogrelCompletedNCT01263093Phase 1Results posted
• N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major DepressionTerminatedNCT01260649Phase 4Results posted
• Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive DisorderCompletedNCT01255787Phase 2/3Results posted
• Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Adults With Fatigue Associated With Major Depressive DisorderCompletedNCT01254305Phase 2Results posted
• The Effects of Dopamine on Reward ProcessingCompletedNCT01253421Phase 1Results posted
• A Pharmacokinetic Study of the Coadministration of LY2216684 With SertralineCompletedNCT01250873Phase 1Results posted
• Lexapro for Major Depression in Patients With EpilepsyTerminatedNCT01244724Phase 4Results posted
• Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for BenzodiazepinesTerminatedNCT01244711Phase 4Results posted
• A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.CompletedNCT01243957Phase 1Results posted
• A Study of LY2216684 in Participants With Impaired Hepatic FunctionCompletedNCT01241435Phase 1Results posted

← Depressive Disorder, Major overview